| |
|
Access to drug funding
in Canada
Towards an efficient, fair, safe, ethical
and simple system
Emily Andrews and Susan Usher
More>>
|
 |

Maintenance therapy in
advanced NSCLC
Encouraging approaches
Roger Y. Tsang, MD, FRCPC and
Charles A. Butts, MD, FRCPC
More>>
|
| |
 |

The effects of androgen
deprivation on intimacy
Early interventions to minimize
emotional suffering
Lauren M. Walker, BA and John W. Robinson,
PhD, RPsych La
More>>
|
| |
 |

Five-year experience of McGills
Adolescent and Young Adult Program
Challenges and successes
Michael Palumbo, MD, PhD, Petr Kavan,
MD, PhD et al
More>>
|
 |
|
|
 |
|
We welcome your
letters and suggestions for future articles.
Please address
correspondence to Emily Andrews, Managing Editor, at andrews@parkpub.com
|
| |
Back
to Top of Page |
|
| |
|

Review of important
clinical trials with commentaries by Canadian experts
The 50th American Society of Hematology
Annual Meeting
Tyrosine kinase inhibitors
in early chronic phase CML
A. Robert Turner MD, FRCPC
Rituximab added to standard
therapy in advanced CLL
Pentostatin replacing fludarabine in early CLL
Flavopiridol in relapsed CLL
Loree Larratt, MD, FRCPC
More>>

The growing role of private sector
payment for cancer care
Kong Khoo, MD, FRCPC
More>>

Selected abstracts from the 2009 Annual
Meeting of CAMO
More>>
|
|

Controlling nausea and vomiting in patients
undergoing chemotherapy
Toward more effective clinical practice
David Warr, MD, FRCPC and Carlo DeAngelis, PharmD
More>>
|
|
|
|